atropine has been researched along with raclopride in 10 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,802 | 132 | 419 |
| Protein | Taxonomy | atropine (IC50) | raclopride (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
| D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Carino, MA; Horita, A | 1 |
| Coffin, VL; Cohen, M; Iorio, LC | 1 |
| Fowler, CJ; Thorell, G | 1 |
| Brent, PJ; Chahl, LA | 1 |
| Ciriello, J; Kirouac, GJ | 1 |
| Alcock, SJ; Crocker, AD; Hemsley, KM | 1 |
| Crocker, AD; Hemsley, KM | 1 |
| Getova-Spassova, D; Krustev, A; Spassov, V; Turijski, V | 1 |
10 other study(ies) available for atropine and raclopride
| Article | Year |
|---|---|
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
D-1 agonist, SKF 38393, but not a D-2 agonist, produces a cholinergically mediated analeptic effect in rabbits.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Atropine; Atropine Derivatives; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agents; Dopamine Antagonists; Ergolines; Male; Oxotremorine; Parasympathetic Nervous System; Pentobarbital; Physostigmine; Quinpirole; Rabbits; Raclopride; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1991 |
Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Topics: Administration, Oral; Animals; Atropine; Avoidance Learning; Benzazepines; Dopamine Antagonists; Drug Synergism; Escape Reaction; Haloperidol; Male; Parasympatholytics; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine | 1991 |
Antagonist effects of the enantiomers of 3-PPP towards alpha 1-adrenoceptors coupled to inositol phospholipid breakdown in the rat cerebral cortex.
Topics: Animals; Antiparkinson Agents; Atropine; Carbachol; Cerebral Cortex; Haloperidol; In Vitro Techniques; Inositol Phosphates; Male; Norepinephrine; Phenoxybenzamine; Piperidines; Prazosin; Raclopride; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Salicylamides; Stereoisomerism; Sugar Phosphates | 1987 |
Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Atropine; Behavior, Animal; Clozapine; Dizocilpine Maleate; Female; Guinea Pigs; Ketamine; Kinetics; Male; Morphine; Motor Activity; Naloxone; Phenazocine; Raclopride; Radioligand Assay; Receptors, sigma; Remoxipride; Salicylamides; Substance Withdrawal Syndrome | 1993 |
Cardiovascular depressor responses to stimulation of substantia nigra and ventral tegmental area.
Topics: Analysis of Variance; Animals; Atropine; Benzazepines; Blood Pressure; Brain Mapping; Dopamine Antagonists; Glutamic Acid; Heart Rate; Hexamethonium; Male; Mesencephalon; Microinjections; Muscarinic Antagonists; Neurons; Nicotinic Antagonists; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Stimulation, Chemical; Substantia Nigra; Tegmentum Mesencephali | 1997 |
Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy.
Topics: Animals; Atropine; Autoradiography; Behavior, Animal; Brain; Catalepsy; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Muscarinic Antagonists; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Muscarinic; Substantia Nigra | 2001 |
Atropine reduces raclopride-induced muscle rigidity by acting in the ventral region of the striatum.
Topics: Animals; Atropine; Basal Ganglia; Brain Mapping; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electromyography; Injections, Intraventricular; Injections, Subcutaneous; Male; Muscarinic Antagonists; Muscle Rigidity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Time Factors | 2002 |
Influence of tacrine on dopamine-induced reactions of the gastric smooth muscle of rats.
Topics: Animals; Atropine; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Raclopride; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, Dopamine D2; Stomach; Tacrine; Time Factors | 2004 |